Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.
Springer Science and Business Media LLC
MetadataShow full item record
Cunningham, J., Cicek, M., Larson, N., Davila, J., Wang, C., Larson, M., Song, H., et al. (2014). Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.. Sci Rep, 4 4026. https://doi.org/10.1038/srep04026
We evaluated homologous recombination deficient (HRD) phenotypes in epithelial ovarian cancer (EOC) considering BRCA1, BRCA2, and RAD51C in a large well-annotated patient set. We evaluated EOC patients for germline deleterious mutations (n = 899), somatic mutations (n = 279) and epigenetic alterations (n = 482) in these genes using NGS and genome-wide methylation arrays. Deleterious germline mutations were identified in 32 (3.6%) patients for BRCA1, in 28 (3.1%) for BRCA2 and in 26 (2.9%) for RAD51C. Ten somatically sequenced patients had deleterious alterations, six (2.1%) in BRCA1 and four (1.4%) in BRCA2. Fifty two patients (10.8%) had methylated BRCA1 or RAD51C. HRD patients with germline or somatic alterations in any gene were more likely to be high grade serous, have an earlier diagnosis age and have ovarian and/or breast cancer family history. The HRD phenotype was most common in high grade serous EOC. Identification of EOC patients with an HRD phenotype may help tailor specific therapies.
BRCA1 Protein, BRCA2 Protein, Base Sequence, Carcinoma, Ovarian Epithelial, DNA Methylation, DNA-Binding Proteins, Female, Homologous Recombination, Humans, Middle Aged, Mutation, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Sequence Analysis, DNA
This work was supported by National Institutes of Health grants R01-CA122443, P50-CA136393, P30-CA15083, and the Fred C. and Katherine B. Andersen Foundation. We thank Gary Kenney, M.D. for pathology review of tumor tissue. We thank Craig Luccarini, Caroline Baynes from University of Cambridge for assisting our sample sequencing.
External DOI: https://doi.org/10.1038/srep04026
This record's URL: https://www.repository.cam.ac.uk/handle/1810/285021
Attribution-NonCommercial-NoDerivatives 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-nd/4.0/
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: email@example.com